---
figid: PMC9597127__f1000research-11-137441-g0001
pmcid: PMC9597127
image_filename: f1000research-11-137441-g0001.jpg
figure_link: /pmc/articles/PMC9597127/figure/f2/
number: Figure 2.
figure_title: Analysis of CIBERSORT immune infiltration fractions in select cancer
  types. The myeloid and T cell populations in the TME were compared
caption: 'Myeloid cells were defined as: Monocytes, Macrophages (M0, M1, M2), Dendritic
  Cells (Resting, Activated). T Cells were defined as CD8+, CD4+ (Naïve, Resting Memory,
  Activated Memory), Follicular Helper, and γδ. Data was obtained from Thorsson V
  et. al. Immunity 2018. BRCA, Breast Invasive Carcinoma; GBM, Glioblastoma; HNSC,
  Head and Neck Squamous Cell Carcinoma; LGG, Low Grade Glioma; LUAD, Lung Adenocarcinoma;
  LUSC, Lung Squamous Cell Carcinoma; SKCM, Skin Cutaneous Melanoma; UVM, Uveal Melanoma.'
article_title: cGAS-STING pathway targeted therapies and their applications in the
  treatment of high-grade glioma.
citation: Shashwat Tripathi, et al. F1000Res. 2022;11:1010.
year: '2022'

doi: 10.12688/f1000research.125163.1
journal_title: F1000Research
journal_nlm_ta: F1000Res
publisher_name: F1000 Research Limited

keywords:
- glioblastoma
- cGAS-STING
- STING Agonist
- immune therapies
- tumor microenvironment
- immune cells
- myeloid cells
- T cells

---
